Product Information
LESSINA-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1509 per EA under NDC 00555901467. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 20, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555901467
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075803FDA Approved
3/20/2002
TE Code
AB2
On Market Since
4/22/2002
Price Statistics
The NADAC for LESSINA-28 TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 71.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1509 per EA |
|---|---|
| All-time high | $0.5937 (Apr 13, 2016) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.2621 |
| Average price | $0.3039 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LESSINA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LESSINA-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1509 per EA (NDC 00555901467), effective Aug 19, 2026.
How has the price of LESSINA-28 TABLET changed over time?
Over the history we have for it, the NADAC for LESSINA-28 TABLET has declined 71.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LESSINA-28 TABLET?
Since Nov 28, 2013, the NADAC for LESSINA-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.5937 (Apr 13, 2016), with a median of $0.2621 per EA.
Are there cheaper alternatives to LESSINA-28 TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 25% below LESSINA-28 TABLET.
Who manufactures LESSINA-28 TABLET?
LESSINA-28 TABLET (NDC 00555901467) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.